Evaluation of efficacy and safety of Polyherbal Unani formulations in the treatment of fungal infection.
Phase 2
- Conditions
- Health Condition 1: L00-L08- Infections of the skin and subcutaneous tissueHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2024/02/063170
- Lead Sponsor
- Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Clinically diagnosed and potassium hydroxide mount (KOH) confirmed cases of dermatophytosis.
2.Patients who agree to sign the written consent form and follow the protocol.
Exclusion Criteria
1.Pregnant and lactating women.
2.Patients exclusively affecting the scalp, palms, and soles.
3.Patients suffering from concomitant diseases like psoriasis and eczema.
4Patients suffering from severe systemic and metabolic diseases like diabetes mellitus, hepatorenal dysfunctions etc.
5.Patients having treatment history of less than 7days in case of topical antifungal medication and 30 days in case of oral antifungal agents and systemic corticosteroids.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method